Skip to main content

Table 1 miRNAs correlated with OS of patients treated with temozolomide in TCGA

From: miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase

Variable

Hazard ratio

95% CI

p value

miR-130a

0.558

0.426–0.733

2.48 ∙ 10 −5

miR-222

1.341

1.166–1.541

3.65 ∙ 10 −5

miR-221

1.416

1.187–1.690

0.0001093

miR-20a

0.693

0.560–0.857

0.0007161

  1. CI, confidence interval.